tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Gliosis D005911 6 associated lipids
Kidney Tubular Necrosis, Acute D007683 3 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Hallucinations D006212 4 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Rosacea D012393 13 associated lipids
Pericarditis D010493 6 associated lipids
Hyperpigmentation D017495 11 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Long QT Syndrome D008133 10 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Mycoses D009181 18 associated lipids
Liver Failure D017093 5 associated lipids
Epilepsy, Temporal Lobe D004833 4 associated lipids
Retinoblastoma D012175 12 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Gastroenteritis D005759 4 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Pityriasis D010915 3 associated lipids
Hand Dermatoses D006229 5 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Liver Abscess D008100 6 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Foot Dermatoses D005533 3 associated lipids
Anus Diseases D001004 3 associated lipids
Endomyocardial Fibrosis D004719 4 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Herpesviridae Infections D006566 4 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Pouchitis D019449 3 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Epstein-Barr Virus Infections D020031 3 associated lipids
Labyrinthitis D007762 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Dementia, Vascular D015140 7 associated lipids
Mastocytosis D008415 5 associated lipids
Molluscum Contagiosum D008976 2 associated lipids
Paresis D010291 2 associated lipids
Intracranial Hypertension D019586 4 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Chronic Disease D002908 7 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Filler G and Smith N The need for tacrolimus assay standardization. 2014 Ther Drug Monit pmid:25390282
Sachewsky N et al. Cyclosporin A enhances neural precursor cell survival in mice through a calcineurin-independent pathway. 2014 Dis Model Mech pmid:25056698
Erdinest N and Solomon A Topical immunomodulators in the management of allergic eye diseases. 2014 Curr Opin Allergy Clin Immunol pmid:25054831
Mori T et al. Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients. 2014 Transpl Infect Dis pmid:24494811
Rehman S et al. Effect of different tacrolimus levels on early outcomes after kidney transplantation. 2014 Ann. Transplant. pmid:24509826
Balato A et al. Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes. 2014 Mycoses pmid:24512536
Qin XL et al. In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/P-glycoprotein-mediated absorption and metabolism of tacrolimus. 2014 Drug Metab. Dispos. pmid:24195812
Silva-Cunha A et al. Evaluation of the pharmacokinetics and ocular tolerance of a microemulsion containing tacrolimus. 2014 J Ocul Pharmacol Ther pmid:24199740
Bruel A et al. Early protocol biopsies in pediatric renal transplantation: interest for the adaptation of immunosuppression. 2014 Pediatr Transplant pmid:24341571
Sapir-Pichhadze R et al. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. 2014 Kidney Int. pmid:24336032
Casey MJ et al. Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. 2014 Transplantation pmid:24717218
Jalil MH et al. Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients. 2014 Br J Clin Pharmacol pmid:23738951
Deng Z et al. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation]. 2014 Zhonghua Er Ke Za Zhi pmid:25224233
Peloso LJ et al. The serum concentration of tacrolimus after ingesting omeprazole: a pilot study. 2014 Transplantation pmid:25221905
Tanaka H et al. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. 2014 Lupus pmid:24651669
Shah NP et al. Treatment of a Crohn's disease-related cutaneous facial lesion with topical tacrolimus. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:25151593
Størset E et al. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. 2014 Br J Clin Pharmacol pmid:25279405
Pichler R et al. De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. 2014 Urol. Int. pmid:25115614
Yan YH et al. Role of FK506 binding protein 12 in morphine-induced μ-opioid receptor internalization and desensitization. 2014 Neurosci. Lett. pmid:24607931
Bogan JS Endocytic cycling of glucose transporters and insulin resistance due to immunosuppressive agents. 2014 J. Clin. Endocrinol. Metab. pmid:25279573
Demmers MW et al. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus. 2014 Transplantation pmid:24157471
Kraus TS et al. Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient. 2014 Acta Haematol. pmid:24157860
Hostettler KE et al. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. 2014 Eur. Respir. J. pmid:23645405
Matsumoto K et al. [Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report]. 2014 Hinyokika Kiyo pmid:25001642
Wu Q et al. Heterogeneity of radiological spectrum in tacrolimus-associated encephalopathy after lung transplantation. 2014 Behav Neurol pmid:24970980
Wohlfahrtova M and Viklicky O Recent trials in immunosuppression and their consequences for current therapy. 2014 Curr Opin Organ Transplant pmid:24905020
Boonyapredee M et al. Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection. 2014 Mil Med pmid:24902140
Stifft F et al. Rectal and sublingual administration of tacrolimus: a single-dose pharmacokinetic study in healthy volunteers. 2014 Br J Clin Pharmacol pmid:24809233
Levy G et al. REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C. 2014 Am. J. Transplant. pmid:24456049
Miller EC et al. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits. 2014 Eur. J. Neurosci. pmid:24713000
Supe-Markovina K et al. Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience. 2014 Pediatr Transplant pmid:24712738
Heilman RL et al. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. 2013 Sep-Oct Clin Transplant pmid:23924146
Benoit S and Hamm H Psoriasis from a prosthesis: unusual Koebner phenomenon in a girl with autoamputation of the leg. 2013 Sep-Oct Pediatr Dermatol pmid:23360396
Zahdi MR et al. Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. 2013 Sep-Oct An Bras Dermatol pmid:24173187
Riva N et al. [Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation]. 2013 Nov-Dec Farm Hosp pmid:24256007
Brodrick B et al. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. 2013 Nov-Dec Clin. Dermatol. pmid:24160287
Bloom RD et al. A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. 2013 Nov-Dec Clin Transplant pmid:24118450
Labirua-Iturburu A et al. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. 2013 May-Jun Clin. Exp. Rheumatol. pmid:23465087
Chen SY et al. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study. 2013 May-Jun Clin Transplant pmid:23432535
Ramirez CB et al. Completely steroid-free immunosuppression in liver transplantation: a randomized study. 2013 May-Jun Clin Transplant pmid:23621629
Krishna N et al. Tacrolimus-induced paranoid delusions and fugue-like state. 2013 May-Jun Gen Hosp Psychiatry pmid:22959421
He L et al. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. 2013 May-Jun J. Nephrol. pmid:22956434
Kanzelmeyer NK et al. Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens. 2013 Mar-Apr Clin Transplant pmid:23414365
Tiwari R et al. Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population. 2013 Mar-Apr J Am Med Inform Assoc pmid:22813760
Albekairy A et al. Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients. 2013 Mar-Apr Saudi J Gastroenterol pmid:23481136
LaMattina JC et al. Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up. 2013 Mar-Apr Clin Transplant pmid:23294013
Alfson ED et al. Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. 2013 Mar-Apr Psychosomatics pmid:22705183
Yoshida EM et al. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection. 2013 Mar-Apr Ann Hepatol pmid:23396740
Castillo G et al. [Acute cellular rejection in a liver transplantation patient due to changing the brand of a generic immunosuppressant]. 2013 Jul-Sep Rev Gastroenterol Mex pmid:23866966
Bechstein WO et al. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients. 2013 Jul-Aug Transplant. Proc. pmid:23953523
Zhao YJ et al. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis. 2013 Jul-Aug Transplant. Proc. pmid:23953533
Weiler N et al. Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? 2013 Jul-Aug Transplant. Proc. pmid:23953543
Stringa P et al. Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. 2013 Jul-Aug Transplant. Proc. pmid:23953566
Tachibana A et al. Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. 2013 Jul-Aug Xenotransplantation pmid:23683097
Favi E et al. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 2013 Jul-Aug Clin Transplant pmid:23710603
Eberlin M et al. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. 2013 Jul-Aug Transplant. Proc. pmid:23726723
Satyanarayan HS et al. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. 2013 Jul-Aug Indian J Dermatol Venereol Leprol pmid:23760325
Babalola O and Strober BE Treatment of atopic dermatitis in pregnancy. 2013 Jul-Aug Dermatol Ther pmid:23914886
Conti R et al. Jessner-Kanof disease: two effective and sure therapeutic options. 2013 Jul-Aug Dermatol Ther pmid:23914897
Chakkera HA et al. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375287
Tian Ch et al. B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375291
Yao B et al. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. 2013 Jan-Feb Transplant. Proc. pmid:23375298
Miyazaki T et al. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375323
Chang HY et al. Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. 2013 Jan-Feb Transplant. Proc. pmid:23375324
Al Nahdi N et al. First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. 2013 Jan-Feb Ann Hepatol pmid:23293209
Seco-Melantuche R et al. [Incidence of drug-induced thrombocytopenia in hospitalized patients]. 2013 Jan-Feb Farm Hosp pmid:23461497
Rao V et al. A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus. 2013 Jan-Feb Transplant. Proc. pmid:23267806
Langone A et al. Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. 2013 Jan-Feb Clin Transplant pmid:22861144
Shiba H et al. Switching from tacrolimus to cyclosporine A to prevent primary biliary cirrhosis recurrence after living-donor liver transplantation. 2013 Apr-Jun Int Surg pmid:23701152
Adamu B et al. New-onset diabetes after renal transplantation: a case series as seen in a Nigerian kidney transplant population. 2013 Apr-Jun Niger J Clin Pract pmid:23563475
Cangemi G et al. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood. 2013 Apr-Jun Int J Immunopathol Pharmacol pmid:23755756
González-Guerrero C et al. Calcineurin inhibitors recruit protein kinases JAK2 and JNK, TLR signaling and the UPR to activate NF-κB-mediated inflammatory responses in kidney tubular cells. 2013 Toxicol. Appl. Pharmacol. pmid:23958496
Tanaka E and Yamanaka H [DMARDs (disease-modifying antirheumatic drugs)]. 2013 Nippon Rinsho pmid:23961667
Ren H et al. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. 2013 Am. J. Nephrol. pmid:23343906
Cardet JC and Boyce JA Addition of mycophenolate mofetil to tacrolimus is associated with decreases in food-specific IgE levels in a pediatric patient with liver transplantation-associated food allergy. 2013 J Allergy Clin Immunol Pract pmid:24229832
Lee SC et al. Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides. 2013 PLoS Pathog. pmid:24039585
Nakamura T et al. Co-stimulation with bone morphogenetic protein-9 and FK506 induces remarkable osteoblastic differentiation in rat dedifferentiated fat cells. 2013 Biochem. Biophys. Res. Commun. pmid:24064349
Pereira MJ et al. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. 2013 Mol. Cell. Endocrinol. pmid:23160140
Thongprasom K et al. Novel therapies for oral lichen planus. 2013 J. Oral Pathol. Med. pmid:23668304
Kyriakou A et al. Treatment of male genital lichen sclerosus with clobetasol propionate and maintenance with either methylprednisolone aceponate or tacrolimus: a retrospective study. 2013 J Dermatolog Treat pmid:23472631
Lee SE et al. Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction. 2013 Exp. Dermatol. pmid:23174045
Sadilkova K et al. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS. 2013 Clin. Chim. Acta pmid:23473895
Saliba F et al. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients. 2013 Med. Mycol. pmid:22800082
Chen D et al. Novel single nucleotide polymorphisms in interleukin 6 affect tacrolimus metabolism in liver transplant patients. 2013 PLoS ONE pmid:23991193
Annunziato RA et al. Strangers headed to a strange land? A pilot study of using a transition coordinator to improve transfer from pediatric to adult services. 2013 J. Pediatr. pmid:23993138
Mo S et al. Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011. 2013 Appl. Microbiol. Biotechnol. pmid:23053074
Cavallucci V et al. Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease. 2013 Neuromolecular Med. pmid:23821337
Sartori-Valinotti JC et al. A 10-year review of otic lichen planus: the Mayo Clinic experience. 2013 JAMA Dermatol pmid:23824252
Isoherranen K et al. [Skin problems in a swollen lower limb]. 2013 Duodecim pmid:24159716
Goyal RK et al. Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation. 2013 Biol. Blood Marrow Transplant. pmid:23266742
Jeong JH et al. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model. 2013 Biochem. Biophys. Res. Commun. pmid:23523788
Hickey MD et al. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. 2013 Liver Transpl. pmid:23526600
Cadou A et al. The Kin1 kinase and the calcineurin phosphatase cooperate to link actin ring assembly and septum synthesis in fission yeast. 2013 Biol. Cell pmid:23294323
Linnert M et al. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction. 2013 Biochemistry pmid:23418784
Arai Y et al. Syndrome of inappropriate antidiuretic hormone secretion induced by tacrolimus following allogeneic cord blood transplantation. 2013 Intern. Med. pmid:23728560
Khuu T et al. Pomegranate-containing products and tacrolimus: a potential interaction. 2013 J. Heart Lung Transplant. pmid:23200637
Caplan AL Ensuring the future of uterine transplantation. 2013 Fertil. Steril. pmid:23200690
Patel CG et al. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. 2013 Xenobiotica pmid:22934787
Borio S et al. Proliferative and necrotising otitis externa in a cat without pinnal involvement: video-otoscopic features. 2013 J. Feline Med. Surg. pmid:23197497
Kovermann M and Balbach J Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein. 2013 Biophys. Chem. pmid:23268194